Learn More
Medchemexpress LLC Gamitrinib TPP hexafluorophosphate | 1131626-47-5 | 99.7% | 1036.03 | C52H65F6N3O8P2 | 10 MG

Supplier: Medchemexpress LLC HY102007A10MG
Gamitrinib TPP hexafluorophosphate is a mitochondria-targeted HSP90 inhibitor that selectively accumulates in the mitochondrial matrix and disrupts mitochondrial Hsp90 function. It is used in biochemical and cell-based cancer research to induce mitochondrial dysfunction and mitophagy and to probe mitochondrial protein homeostasis. The compound is supplied as a high-purity, pale purple solid suitable for in vitro studies.
- Selectively targets mitochondria via a triphenylphosphonium moiety.
- Inhibits mitochondrial HSP90 ATPase activity to disrupt protein folding.
- Demonstrates anticancer activity in cell-based models.
- High purity suitable for research applications.
- Soluble in DMSO; insoluble in water.
- Stable when stored under recommended low-temperature conditions.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.